Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance
Urs Eiholzer(Center for Pediatric Endocrinology Zurich), A. Prader(University of Zurich), R. Gisin(Center for Pediatric Endocrinology Zurich), Hans C. Steinert(University of Zurich), Susi Kriemler(University of Zurich), Toni Torresani(University Children's Hospital Zurich), Claudia Weinmann(University of Zurich), M. Zachmann(University of Zurich)
Cited by 96
Related Papers
European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism
|The Journal of Clinical Endocrinology & Metabolism|2014|569
Variations in accelerometry measured physical activity and sedentary time across Europe – harmonized analyses of 47,497 children and adolescents
|International Journal of Behavioral Nutrition and Physical Activity|2020|434
European best practice guidelines for cystic fibrosis neonatal screening
|Journal of Cystic Fibrosis|2009|245
European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism
|Hormone Research in Paediatrics|2014|205
Dual fortification of salt with iodine and microencapsulated iron: a randomized, double-blind, controlled trial in Moroccan schoolchildren
|American Journal of Clinical Nutrition|2003|169